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A novel role for Rab5–GDI in ligand sequestration into 
clathrin-coated pits
Hilary McLauchlan*, Jane Newell*, Nick Morrice†, Andrew Osborne*, Michele
West* and Elizabeth Smythe*
Background: Clathrin-coated pits are formed at the plasma membrane by the
assembly of the coat components, namely clathrin and adaptors from the
cytosol. Little is known about the regulation and mechanism of this assembly
process.
Results: We have used an in vitro assay for clathrin-coated pit assembly to
identify a novel component required for the invagination of newly formed coated
pits. We have purified this cytosolic component and shown it to be a complex
of Rab5 and GDI (guanine-nucleotide dissociation inhibitor), that was previously
demonstrated to be involved in downstream processing of endocytic vesicles.
Using a combination of quantitative electron microscopy and in vitro
endocytosis assays, we have demonstrated that although coat proteins and
ATP are sufficient to increase the number of new coated pits at the cell surface
in permeabilised cells, the Rab5–GDI complex is required for ligand
sequestration into clathrin-coated pits. 
Conclusions: We have identified Rab5 as a critical cytosolic component
required for clathrin-coated pit function. Given the well-established role of Rab5
in the fusion of endocytic vesicles with endosomes, our results suggest that
recruitment of essential components of the targeting and fusion machinery is
coupled to the formation of functional transport vesicles.
Background
The cellular uptake of many biologically important macro-
molecules is mediated by clathrin-coated pits and coated
vesicles. Coated pits assemble at the plasma membrane
following recruitment of coat proteins from the cytosol
[1–3]. The coat is composed of clathrin, which acts as a
structural scaffold [4], and a complex of adaptor proteins,
which form an inner layer linking transmembrane recep-
tors to the clathrin lattice [5]. The adaptor complex AP2 is
found specifically in plasma membrane coated pits and
vesicles, whereas AP1 is localised to clathrin-coated vesi-
cles which bud from the trans-Golgi network [6]. Studies
of cells that have been freeze-fractured and deep-etched
reveal that clathrin initially assembles onto the membrane
as a planar lattice composed of hexagons and, as the lattice
becomes increasingly invaginated, there is a conversion of
hexagons to pentagons [7,8]. Little is known about the
molecular mechanisms that drive clathrin-coated pit
assembly and coated vesicle formation [9]. However,
the recent development of cell-free systems that measure
distinct and overlapping stages in coated pit and vesicle
formation [10–12] has created an opportunity to identify
the essential components that regulate these processes.
Previous studies using this approach have demonstrated
that both the formation of new coated pits and the
budding process which forms coated vesicles require
cytosolic components and ATP [10,11]. Clathrin-coated pit
assembly is stimulated by purified AP2 adaptor complexes,
but only in the presence of clathrin and cytosol [12], indi-
cating that, in addition to the known structural components
of the coat, other cytosolic components are required on the
pathway to vesicle formation. These might include factors
required downstream of vesicle formation, for example, for
correct vesicle targeting and/or fusion.
The targeting of transport vesicles such as clathrin-coated
vesicles to their acceptor compartment is tightly regulated.
One class of specific proteins involved in the maintenance
of targeting fidelity is the Rab family, comprising at least 30
small GTP-binding proteins that are known to be involved
in the regulation of membrane trafficking in the endocytic
and exocytic pathways [13]. Members of the Rab family
show distinct subcellular localisations [14], and various
transport processes have been shown to be dependent on
functional Rab proteins [15], but their precise mechanism
of action has yet to be fully elucidated. Studies in yeast
have indicated that Rab proteins interact with and activate
SNARE proteins (soluble N-ethylmaleimide-sensitive
fusion protein attachment protein (SNAP) receptors)
[16,17]. SNARE proteins are integral membrane proteins
which confer vesicle targeting specificity, and comprise two
families: v-SNAREs are thought to direct transport vesicles
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to their correct target membrane where the v-SNARE
interacts with a cognate t-SNARE. Although implicated in
the assembly of SNARE complexes, Rab proteins have not,
however, been detected in these complexes and a role for
Rabs as catalysts in v-SNARE and t-SNARE interactions
has been proposed [18–20]. It is also postulated that Rab
proteins have a proof-reading function which maintains the
fidelity of transport by ensuring that there is correct pairing
between v-SNARE and t-SNARE partners.
Rab5 has been localised to early endosomes and the
plasma membrane. Early studies using in vitro assays that
reconstitute early endosome fusion [21] indicated that
Rab5 is essential for homotypic fusion [22]. Overexpres-
sion of wild-type Rab5 enhanced the rate of transferrin
internalisation, and overexpression of Rab5 mutants defi-
cient in GTP binding inhibited transferrin uptake [23].
These findings suggested that Rab5 activity is rate-limit-
ing in the early endocytic pathway. Overexpression of the
wild-type protein caused an accumulation of large endoso-
mal structures, which differed from the small vesicular
structures seen in cells overexpressing the mutant protein.
Rab5 was also shown to be a component of clathrin-coated
vesicles [23]. Taken together, these results indicated a
role for Rab5 in fusion between clathrin-coated vesicles
and early endosomes.
Rab proteins are present in both membrane-bound and
soluble pools. In the cytosol, these proteins are complexed
to Rab guanine-nucleotide dissociation inhibitor (GDI)
[24]. GDI binds to Rabs that are in the GDP-bound, inac-
tive conformation and targets these proteins to their site of
action. GDI then dissociates from the membrane and a
guanine-nucleotide exchange factor mediates GTP/GDP
exchange on the membrane-bound Rab protein [25,26].
This chaperone activity of GDI is important in directing
Rab proteins to the correct target membrane. Rab proteins
that are complexed to delipidated bovine serum albumin
can be delivered to membranes, but the specificity of
delivery is lost [27]. It is as yet unclear how GDI confers
specificity to this delivery process.
In this study, we have demonstrated that coat proteins, in
the presence of an energy source, are sufficient for the for-
mation of new coated pits in permeabilised A431 cells. A
cytosolic component(s) is, however, essential for these
clathrin-coated pits to sequester transferrin efficiently. We
have purified this component and shown it to consist of a
complex of Rab5 and GDI (Rab5–GDI). These results
indicate a novel role for the Rab5–GDI complex at the
very earliest stages of the endocytic pathway. Further-
more, we show that Rab proteins are required at all stages
on the pathway to coated vesicle formation. Thus, there
appears to be a direct link between the processes of trans-
port vesicle formation and the recruitment of components
required for subsequent fusion reactions.
Results
Rab5–GDI is the cytosolic component that supports
adaptor-dependent coated pit assembly
Stage-specific assays in permeabilised A431 cells have
been developed that measure different and overlapping
events on the pathway to clathrin-coated vesicle forma-
tion. A derivative of transferrin termed BSST, which is
biotinylated via a cleavable disulphide linkage, is used as a
reporter molecule. Both the sequestration of BSST into
deeply invaginated coated pits and its internalisation into
coated vesicles are measured by a loss of accessibility of
BSST to exogenously added avidin. The internalisation of
BSST into clathrin-coated vesicles also renders it resistant
to the small membrane impermeant reducing agent
MesNa [11]. From previous studies, we know that inac-
cessibility to avidin measures new coated pit formation,
the growth and invagination of existing pits, and the scis-
sion step that gives rise to coated vesicles; in contrast, the
MesNa-resistance assay measures only the late stages of
coated vesicle budding [10,11]. Figure 1a illustrates
schematically the ‘substrates’ and reaction products mea-
sured by the different in vitro assays.
Both the assembly and the budding of coated pits are
dependent on cytosolic factors. Adaptors are limiting in
our cytosolic preparations, so the early stages of coated
pit assembly may be stimulated by purified adaptor pro-
teins in a cytosol-dependent and clathrin-dependent
manner [12]. In order to elucidate further the mecha-
nism of coat assembly, we aimed to purify the cytosolic
component(s) essential for this process. Bovine brain
cytosol was fractionated, and the fractions were assayed
for their ability to support adaptor-dependent transferrin
sequestration using the avidin-inaccessibility assay.
Figure 1b illustrates a typical titration curve for cytosol
in the presence and absence of adaptors. In order to
quantify the activity present in cytosol and cytosolic
fractions, we assayed the extent of transferrin sequestra-
tion in the presence and absence of adaptors over a
range of concentrations of cytosol and cytosolic fractions.
Subtraction of the curve observed in the absence of
adaptors from that seen in the presence of adaptors gave
a measure of adaptor-dependent transferrin sequestra-
tion only. We arbitrarily defined a unit of activity as that
amount of protein which gave half-maximal adaptor-
dependent transferrin sequestration. In the absence of
cytosol, the extent of sequestration in the presence of
adaptors and ATP was not significantly greater than that
observed in the presence of ATP alone. Using this assay
system, we have achieved a 2000-fold purification of
a cytosolic activity essential for adaptor-dependent
ligand sequestration to a recovery of approximately 2%
(Table 1).
Unfractionated bovine brain cytosol (Figure 1b) supported
considerable basal transferrin sequestration in the absence
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of added adaptors. This basal activity is lost from more
purified fractions (Figure 1b). Thus, both the purified
cytosolic activity and the adaptor complexes are required
for ligand sequestration. Although the overall efficiency
of sequestration drops in the presence of purified frac-
tions and adaptors compared with that in the presence of
cytosol and adaptors, a comparison of the curves obtained
in the absence and presence of adaptors in Figure 1b
shows that the adaptor-dependent stimulation remains
the same at 10–15% sequestration. This finding
argues that the purified activity fulfils all of the cytosolic
requirements for adaptor-dependent transferrin sequestra-
tion in the permeabilised A431 cell system. In addition, at
each step of the purification procedure we added inactive
fractions to the active fraction in the assay and in no case
did we observe an enhancement of activity.
The final step in the purification procedure was chro-
matography through a Superdex 200 gel filtration column.
Analysis of the eluted fractions by SDS–PAGE revealed
that the activity co-eluted with two bands of molecular
weight 58 kDa and 27 kDa (Figure 2a). This preparation
36 Current Biology, Vol 8 No 1
Figure 1
In vitro endocytosis assays. (a) Intermediates
measured by in vitro assays for endocytosis.
The ‘substrates’ can be either newly
assembled clathrin-coated pits or pits already
present when the cells are permeabilised.
Both of these populations contain transferrin
receptors and can therefore bind biotinylated
ligand, which will be accessible to both avidin
and MesNa. Invagination of both of these
populations of pits results in the sequestration
of ligand into deeply invaginated structures
such that the ligand is no longer accessible to
avidin. Scission of deeply invaginated coated
pits to form coated vesicles results in the
biotinylated ligand becoming inaccessible to
avidin and resistant to MesNa. It appears that
only a ‘primed’ population of pits already
present in permeabilised cells is capable of
undergoing scission. (b) Assay for adaptor-
dependent transferrin sequestration. Bovine
brain cytosol or the Superdex 200 pool were
titrated in the presence of an ATP-
regenerating system and the presence or
absence of adaptors, and the amount of
biotinylated transferrin sequestered was
measured using the avidin inaccessibility
assay as described in Materials and methods.
Background sequestration observed in the
presence of an ATP-regenerating system and
in the absence of cytosol (~20% of total)
have been subtracted in each case. The
extent of sequestration seen in the presence
of adaptors and the absence of cytosol or
cytosolic fractions did not exceed the amount
of sequestration seen in the presence of
ATP alone.
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was subjected to in-solution digestion with cyanogen
bromide and, after western blotting, amino-terminal
sequence from four fragments was obtained. Comparison
of these sequences to sequences in the SwissProt data-
base revealed 100% identity to RabGDIα (Figure 2b). To
confirm the identity of the 58 kDa band, antiserum was
raised against peptides corresponding to distinct regions
of GDI (see Materials and methods). This antiserum
cross-reacted with the 58 kDa band on western blots
(Figure 2c). 
One of the well-documented functions of GDI is to chap-
erone Rab proteins, which are required for the fidelity of
transport, to the correct target membrane. The presence
of a 27 kDa band in the final active fraction suggested that
this protein might be a member of the Rab family. Given
the well-established role of Rab5 in the early endocytic
pathway and its localisation to the plasma membrane and
early endosomes [28], it seemed a likely candidate for the
27 kDa protein. This protein was confirmed to be Rab5 by
western blotting using a monoclonal antibody to Rab5
(Figure 2c). 
To confirm that GDI was indeed a component of the
activity required for adaptor-dependent transferrin
sequestration, we used affinity-purified anti-peptide anti-
bodies against GDI (see Materials and methods) to specif-
ically deplete GDI from cytosol (Figure 3a). Treatment of
cytosol with irrelevant sheep serum coupled to protein-
G–Sepharose reduced adaptor-dependent transferrin
sequestration to 80% of control (untreated cytosol). A
similar reduction in activity was observed in the presence
of protein-G–Sepharose alone (data not shown). Depletion
of GDI from cytosol using anti-peptide 1 antibodies abol-
ished adaptor-dependent transferrin sequestration com-
pletely, and depletion with anti-peptide 2 antibodies
substantially inhibited (> 60%) adaptor-dependent sequ-
estration (Figure 3b). For both antibodies, the extent of
inhibition observed in the in vitro endocytosis assay corre-
lated well with the degree of depletion of GDI from the
fraction (Figure 3a). 
The 27 kDa band in our most purified fraction which
cross-reacted with anti-Rab5 antibodies was the major
polypeptide in the molecular weight range 20–30 kDa. To
confirm that the activity was specific for Rab5 rather than
other Rab proteins, we immunodepleted Rab5 from
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The cytosolic activity required for adaptor-dependent transferrin
sequestration is a complex of Rab5–GDI. (a) Analysis by 10%
SDS–PAGE of the purified active fraction after gel filtration through
Superdex 200. The gel was silver-stained and the molecular weights of
standards (in kDa) are as indicated. The positions of the 58 kDa and
27 kDa bands are indicated by arrows. (b) Sequence of bovine brain
RabGDIα. The peptides that were sequenced from our preparation are
indicated by the boxed regions. Two of the peptides sequenced
(residues 106–115 and residues 171–177) showed an atypical
amino-terminal sequence for cyanogen-bromide cleavage and we
assume that this sequence arose as a result of acid cleavage of the
peptides during digestion. (c) Western blot of the active fraction
shown in (a). Arrows indicate a band at 58 kDa which cross-reacts
with anti-GDI antibodies (left panel), and a band at 27 kDa which
cross-reacts with anti-Rab5 antibodies (right panel).
Table 1
Purification of cytosolic activity for adaptor-dependent
sequestration of transferrin into invaginated coated pits.
Specific
Activity Purification Yield
Step Units (Units/mg) (fold) (%)
Cytosol 205,000 50 1 100
Reactive red 54,998 1,742 35 27
MonoQ 36,666 5,555 111 18
Phosphocellulose 7,920 10,000 200 3.9
Superdex 200 4,455 100,000 2,000 2.2
The table shows a typical purification table from 1 kg of bovine brain.
Units are defined in Results.
cytosol. Antiserum against Rab5 almost quantitatively
depleted Rab5 from cytosol (Figure 3c). Addition of
depleted cytosol to permeabilised cells led to > 90%
reduction in adaptor-dependent transferrin sequestration
(Figure 3d), demonstrating that Rab5–GDI represents the
critical component in cytosol that is essential for adaptor-
dependent transferrin sequestration. Purified Rab5–GDI
rescued the ability of cytosol treated with both anti-GDI
and anti-Rab5 antibodies to support adaptor-dependent
transferrin sequestration (Figure 3b,d). Depletion of Rab1
from cytosol had no effect on the ability of cytosol to
support adaptor-dependent sequestration (data not
shown). The active fraction obtained after chromatogra-
phy on phosphocellulose was immunoblotted for Rab1,
Rab4, Rab5 and Rab6. Only Rab5 was detected in this
purified fraction (Figure 3e). Furthermore, during the
course of the purification, we identified, by western blot-
ting, fractions which are highly enriched in other
Rab–GDI complexes, for example, containing Rab1, Rab4
and Rab6 (Figure 3f). None of these fractions could
support adaptor-dependent transferrin sequestration,
however (Figure 3f). 
The association of Rab proteins with their target mem-
branes has been shown to be coupled to nucleotide
exchange [25,26]. We next addressed whether or not
Rab5–GDI involvement in ligand sequestration into
invaginated coated pits also required nucleotide
exchange. We used a recombinant mutant form of Rab5
which preferentially binds xanthosine 5′-triphosphate
(XTP), REP-1:his-Rab5D136N. In the presence of XTP,
this mutant protein supports endosome–endosome
fusion to the same extent as recombinant wild-type Rab5
[29]. Similarly, REP-1:his-Rab5D136N was capable of sup-
porting adaptor-dependent transferrin sequestration to
the same extent, and within the same concentration
range, as biochemically purified Rab5–GDI. Importantly,
this effect was completely dependent on the presence of
XTP, demonstrating that nucleotide exchange on Rab5
is essential for adaptor-dependent ligand sequestration
(Figure 4).
GDI inhibits coated pit assembly and scission
A number of studies have demonstrated that GDI acts as
an inhibitor of transport reactions in vitro by solubilising
38 Current Biology, Vol 8 No 1
Figure 3
Immunodepletion of GDI and Rab5 from
cytosolic extracts. (a) Western blot analysis of
bovine brain cytosol immunodepleted of GDI
using affinity-purified polyclonal sheep
antibodies specific for GDI (see Materials and
methods). Pellets (P) and supernatants (S)
after immunodepletion with non-specific
sheep antiserum (N/S), anti-peptide 1
(αGDI1) and anti-peptide 2 (αGDI2) were
immunoblotted using anti-GDI antiserum. (b)
Effect of immunodepletion of GDI on adaptor-
dependent stimulation of sequestration.
Cytosol was treated with either non-specific
serum (N/S), anti-peptide 1 (αGDI1) or anti-
peptide 2 (αGDI2), coupled to protein-
G–sepharose and then assayed for the ability
to support adaptor-dependent transferrin
sequestration. The fractions used correspond
to the supernatants shown in Figure 3a.
Purified Rab5–GDI (1 µg) was added to anti-
peptide 1-depleted cytosol as indicated. (c)
Western blot analysis of bovine brain cytosol
immunodepleted of Rab5 using anti-Rab5
antiserum coupled to protein-A–sepharose.
Pellets (P) and supernatants (S) after
immunodepletion with non-specific rabbit
serum (N/S) or anti-Rab5 antiserum (αRab5).
(d) Effect of immunodepletion of Rab5 on
adaptor-dependent transferrin sequestration.
Cytosol was treated with either non-specific
serum (N/S) or anti-Rab5 antibodies (αRab5)
coupled to protein-A–Sepharose and then
assayed for the ability to support adaptor-
dependent transferrin sequestration. The
fractions used correspond to the supernatants
shown in Figure 3c. Purified Rab5–GDI (1 µg)
was added to Rab5-depleted cytosol as
indicated. (e) Western blot of the cytosolic
fraction after phosphocellulose
chromatography using antibodies raised
against Rab1, Rab4, Rab5 and Rab6. (f)
Western blots using antibodies against Rab1,
Rab4, Rab5 and Rab6 showing the fractions
in which each of these proteins was most
enriched during the purification of Rab5–GDI.
RRFT, flow-through from reactive red column;
QFT, flow-through from MonoQ; PCFT, flow-
through from phosphocellulose column.
Adaptor-dependent transferrin sequestration
of each of these fractions was measured
(activity).
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Rab proteins from the membrane (see references within
[24]). Given that, in our permeabilised cell system, exoge-
nously added adaptors stimulate only a limited number of
steps on the pathway to coated vesicle formation, we
wanted to investigate whether Rab5 was required at other
stages in coated vesicle formation. Permeabilised cells
were incubated with increasing amounts of GDI purified
from bovine brain [30], and the extent of transferrin
sequestration into deeply invaginated coated pits and its
internalisation into coated vesicles was measured using
the assays for avidin inaccessibility, MesNa resistance and
adaptor-dependent ligand sequestration. Figure 5a–c
shows that in all three assays GDI was inhibitory, with
half-maximal inhibition occurring at ~0.6 µM and full inhi-
bition occurring at 2 µM in each assay. This inhibitory
effect correlated with the removal of 47% of Rab5 from
the membranes as determined by western blotting
(Figure 5d). These data demonstrate that Rab5 is required
at all stages in coated vesicle formation.
Rab5–GDI acts after coat protein recruitment to promote
sequestration
Rab5–GDI supports adaptor-dependent ligand sequestra-
tion and adaptors have previously been shown to act at an
early stage(s) of coat assembly [12]. Rab5–GDI could,
therefore, act either to initiate new coated pits or to
promote sequestration. To further characterise the stage at
which Rab5–GDI acts, we carried out a morphological
analysis of the role of the complex and adaptors in this
system. Permeabilised cells were incubated under a
variety of conditions and processed for electron
microscopy. A quantitative analysis of the number of
coated pits per nucleus was carried out using the disector
method, which samples particles with equal probability
regardless of their size and provides an unbiased estimate
of the number of particles [10,31]. Rab5–GDI alone had
no effect on the numbers of coated pits at the plasma
membrane (Table 2). In contrast, adaptors alone, in the
presence of ATP, led to a striking 2–3-fold increase in the
number of coated pits per nucleus (Table 2). The increase
was absolutely dependent on the presence of ATP: in the
presence of an ATP-depleting system, adaptors were not
capable of effecting de novo coated pit formation. 
Our biochemical assays have demonstrated that the
extent of sequestration of transferrin seen in the pres-
ence of adaptors and ATP alone is modest. Maximum
sequestration requires the presence of cytosol and, as
described above, this cytosolic requirement can be com-
pletely fulfilled by Rab5–GDI. The Rab5–GDI complex
itself does not enhance sequestration in the absence of
adaptors. Thus, although coat proteins in the presence of
ATP are capable of forming new coated pits, these pits
can only sequester ligand in the presence of Rab5–GDI,
demonstrating that Rab5–GDI acts after the recruitment
of coat proteins.
A role for clathrin in adaptor-dependent ligand
sequestration
In the presence of Rab5–GDI and purified adaptors, trans-
ferrin was sequestered into coated pits, raising the ques-
tion as to the source of clathrin. It should be noted that,
although > 95% of the soluble material, as assayed by
release of lactic dehydrogenase, is lost from the cells
during the permeabilisation process [10], the membranes
are not rigorously stripped of peripheral membrane pro-
teins. In order to investigate whether clathrin might be
recruited from the A431 cell membranes for incorporation
into coated pits, the permeabilised cell membranes were
stripped of clathrin using 100 mM Tris pH 7.8. This
process resulted in the loss of ~90% of the membrane-
associated clathrin (Figure 6a). When these stripped mem-
branes were assayed for adaptor-dependent transferrin
sequestration, they retained the ability to sequester trans-
ferrin in the presence of cytosol (Figure 6b). This finding
was consistent with our previous results showing that
clathrin may be recruited from the cytosol to participate in
coated pit assembly [12]. No sequestration was observed
in the presence of purified Rab5–GDI and adaptors,
however (Figure 6b). This contrasts with unstripped cells,
in which addition of adaptors and Rab5–GDI is sufficient
Figure 4
REP-1:his-Rab5D136N complex can support adaptor-dependent
transferrin sequestration in the presence of XTP. The extent of
transferrin sequestration in permeabilised cells was measured in the
presence of purified Rab5–GDI (50 nM), REP-1:his-Rab5D136N
(50 nM), adaptors (10 µg), and XTP (1 mM) as indicated. Background
sequestration measured in the presence of an energy-regenerating
system alone has been subtracted, and each value represents the mean
of duplicate samples which differed by less than 10% of each value.
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to stimulate coated pit assembly in permeabilised cells
(Figure 1b). The ability to sequester transferrin was
restored in the stripped cells in the presence of purified
clathrin. As there is no clathrin in our purified preparations
of Rab5–GDI (data not shown), it seems likely that clathrin
is recruited from the membranes of unstripped, perme-
abilised cells to participate in transferrin sequestration.
Discussion
Many questions remain unanswered concerning the forma-
tion of clathrin-coated pits and coated vesicles [9] and to
address these questions it is necessary to identify all of the
molecular components required for these processes. The
reconstitution of clathrin-coated pit assembly and coated
vesicle formation in permeabilised A431 cells has demon-
strated that cytosol and ATP promote both new coated pit
formation and coated vesicle budding [10–12]. Because
adaptors are limiting in cytosol, addition of purified adap-
tors stimulates coated pit assembly as measured by ligand
sequestration into deeply invaginated pits, and this stimu-
lation requires both clathrin and other cytosolic compo-
nents [12]. In this study, we have purified the cytosolic
component(s) required for adaptor-dependent transferrin
sequestration and shown it to be a complex of Rab5 and
GDI. We also show that the Rab5–GDI complex acts after
new coated pits have assembled and is essential for ligand
sequestration. Thus, the components that will subse-
quently be required for correct targeting and fusion are
built into the nascent transport vesicle and indeed are nec-
essary for clathrin-coated pits to sequester ligand. 
Rab5–GDI is essential for clathrin-coated pit function
In this study, we have shown that new coated pits form
in permeabilised A431 cells in the presence of added
40 Current Biology, Vol 8 No 1
Figure 5
GDI inhibits all of the stage-specific assays for
clathrin-coated vesicle formation. GDI purified
from bovine brain was added to permeabilised
cells at the indicated concentrations, (a,b) in
the presence of cytosol (1.5 mg/ml), ATP and
BSST, and (c) in the presence of reactive red
fraction (0.09 mg/ml), ATP, BSST and purified
adaptors (10 µg). The final volume of the
reaction mix was 40 µl. (a) Coated vesicle
budding was measured using the MesNa
resistance assay. (b) Coated pit assembly,
invagination and scission was measured using
the avidin inaccessibility assay. (c) The
invagination of new coated pits was measured
using the adaptor-dependent assay. The
results shown are from a typical experiment
performed three times and each point
represents the mean of duplicate values
which differed from each other by less than
10%. (d) Membranes were incubated with
GDI at the indicated concentrations for
30 min at 37°C. The membranes were then
pelleted and both membrane pellets and
supernatants were subjected to SDS–PAGE
followed by western blotting using anti-Rab5
antibodies.
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Table 2
Effect of adaptors, Rab5–GDI and ATP on coated pit assembly
in permeabilised A431 cells.
Number of coated pits/nucleus
Incubation conditions ± coefficient of error
+ATP +low cytosol 661 ± 59
+ATP +low cytosol, +adaptors 933 ± 81
+ATP +Rab5–GDI 494 ± 43
+ATP +Rab5–GDI +adaptors 1094 ± 105
+ATP +adaptors 1354 ± 96
–ATP +Rab5–GDI +adaptors 416 ± 39
Numbers of coated pits per nucleus were counted using the double
disector method [31]. The decrease in the number of coated pits per
nucleus in the presence of adaptors and Rab5–GDI or cytosol does
not appear to be significant because in two other experiments where
the number of coated pits per nucleus were counted in the presence
of adaptors and ATP only, the numbers obtained were 921 ± 62 and
1148 ± 117.
adaptors and an energy source. Efficient sequestration of
ligand requires the presence of cytosolic factors,
however. Making no assumptions as to the outcome, we
have fractionated bovine brain cytosol and have identi-
fied Rab5–GDI as the essential cytosolic component
required for adaptor-dependent transferrin sequestration.
We believe that Rab5–GDI and not other Rab–GDI
complexes represents the cytosolic activity required for
adaptor-dependent transferrin sequestration for the fol-
lowing reasons. Firstly, immunodepletion of Rab5 from
cytosol abolishes almost all of the activity required for
adaptor-dependent transferrin sequestration, indicating
that other cytosolic Rab protein complexes cannot sub-
stitute for Rab5–GDI. Secondly, recombinant REP-
1:his-Rab5D136N [29] can also support adaptor-dependent
sequestration with the same concentration optimum
(50 nM) as the purified Rab5–GDI complex. Further-
more, in the course of the purification we identified frac-
tions that were highly enriched in other Rab–GDI
complexes, containing for example Rab1, Rab4 and
Rab6. None of these fractions could support adaptor-
dependent transferrin sequestration, however. We
believe that Rab5–GDI completely fulfils the require-
ment for cytosol in adaptor-dependent transferrin
sequestration in the permeabilised A431 cell system
because the extent of adaptor-dependent sequestration
is the same for cytosol as it is for both the biochemically
purified complex and the recombinant REP-1:his-
Rab5D136N complex. 
Adaptor-dependent transferrin sequestration never
exceeds 10–15% of the total transferrin being sequestered.
This is as expected because this step measures the
sequestration of transferrin receptors into newly formed
coated pits, and there are only a finite number of receptors
that can be included in these pits. The concentration
of Rab5–GDI that supports adaptor-dependent sequestra-
tion is similar to that required to promote
endosome–endosome fusion in vitro [22,29] and, as
expected, is less than the total cellular concentration of
GDI, which has been estimated in CHO cells as ~170 nM,
with higher levels in brain and liver (see references in
[24]). Nucleotide exchange is required for the stimulatory
effects of Rab5 on early endosome fusion [29] and also for
the ypt1-dependent fusion of ER-derived vesicles [32].
Similarly, Rab5–GDI-driven ligand sequestration into
deeply invaginated pits is coupled to nucleotide exchange.
The ability of the mutant REP-1:his-Rab5D136N complex
to support ligand sequestration is dependent on the pres-
ence of XTP. Given that nucleotide exchange is required
for ligand sequestration and that GDI inhibits this reac-
tion (see below), it seems likely that it is the recruitment
of Rab5 to the membrane which is critical for ligand
sequestration. Presumably GDI is acting to effect the
delivery of Rab5 to the membrane, as has been demon-
strated in other systems [25,26].
It should be noted that although we have identified
Rab5–GDI as the cytosolic component required for
adaptor-dependent transferrin sequestration in perme-
abilised A431 cells, we would expect that additional
factors essential for the formation of clathrin-coated pits
and vesicles would have been previously recruited to the
permeabilised cell membranes. Possible candidate pro-
teins might include a member of the ADP-ribosylation
factor (ARF) family of small GTPases, shown to be
involved in the formation of other coated vesicles within
the cell [33,34], or non-neuronal homologues of proteins
that may be involved in the clathrin-mediated uptake of
membrane at the synapse [35,36]. In our study, it appears
likely that clathrin is recruited from the permeabilised cell
membranes to participate in new coated pit assembly, and
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Figure 6
Permeabilised cells stripped of clathrin can use membrane clathrin to
support adaptor-dependent transferrin sequestration. (a) Western blot
analysis of clathrin associated with permeabilised cells. Clathrin
associated with membranes from 106 A431 cells permeabilised in
KSHM (lane 1) or after stripping with 100 mM Tris, pH 7.8 (lane 2). (b)
Permeabilised cell membranes were stripped following
permeabilisation by incubation in 100 mM Tris pH 7.8 for 10 min at
0°C. Membranes were then pelleted and resuspended in KSHM.
These membranes were then assayed for adaptor-dependent ligand
sequestration in the presence of cytosol (30 µg), Rab5–GDI (0.4 µg)
and/or clathrin (10 µg) as indicated. Data are from a typical experiment
and each point represents the mean of duplicate samples which
differed by less than 10%.
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similarly other components may remain associated with
the A431 cell membranes following permeabilisation.
Further evidence for the direct involvement of Rab5 in
clathrin-coated pit assembly and coated vesicle formation
comes from our studies of the effect of GDI on these
processes. GDI not only markedly inhibits adaptor-depen-
dent sequestration of transferrin but, interestingly, also
inhibits all other steps on the pathway to coated vesicle
formation. Exogenous adaptors and Rab5–GDI have no
effect on the later stages of coated vesicle formation, as
measured by the MesNa assay ([12,37]; H.M. and E.S.,
unpublished observations). Previous studies have demon-
strated that the formation of clathrin-coated vesicles in
permeabilised A431 cells appears to result from a popula-
tion of coated pits ‘primed’ for scission upon permeabilisa-
tion [11]. These pits presumably have already recruited
many essential components, including Rab5. Although the
exogenously added Rab5–GDI did not support the scis-
sion step in permeabilised A431 cells, its removal inhib-
ited coated vesicle formation. These data are consistent
with a role for Rab5–GDI in all stages of clathrin-coated
vesicle formation.
A number of lines of evidence demonstrate that Rab5 plays
a major role in the fusion of uncoated clathrin-coated vesi-
cles and early endosomes; indeed Rab5 has been shown to
be a component of clathrin-coated vesicles [23]. Two possi-
bilities could explain how Rab5 might be incorporated into
coated vesicles: it could be recruited as part of the growing
pit, or it could be recruited to clathrin-coated vesicles as has
been shown in vitro [38]. The results of our study demon-
strate that Rab5 is recruited during the process of clathrin-
coated pit formation. In addition, recruitment at this early
stage is critical for coat invagination and coated vesicle scis-
sion. These studies provide the first direct evidence that
Rab5–GDI is required for clathrin-coated vesicle forma-
tion, and they may explain earlier data demonstrating that
the initial rates of transferrin internalisation were enhanced
in cells overexpressing wild-type Rab5 [23]. Rab5 is clearly
limiting in the endocytic pathway, and our evidence that it
is directly involved in clathrin-coated pit formation is con-
sistent with the finding that Rab5 overexpression stimu-
lates transferrin uptake. Similarly, the overexpression
studies demonstrate that the life-time of a coated pit is
reduced by 50% in cells transfected with wild-type Rab5
[23]. In intact cells, other components necessary for coated
pit budding may not be limiting and hence, in the presence
of increased levels of Rab5, the rate of budding from the
cell surface will be enhanced. 
Coat proteins and ATP are sufficient for de novo coated pit
assembly
We have examined the role of individual purified compo-
nents in coated pit assembly in permeabilised cells using
quantitative electron microscopy. Addition of adaptors
resulted in at least a two-fold increase in the number of
coated pits at the cell surface, but only in the presence of
ATP. In permeabilised cells, exogenously added adaptors
and ATP were sufficient for the assembly of new coated
pits, which also showed the distinctive bristle-like coat
that is characteristic of clathrin-coated pits. It seems prob-
able that there is substantial recruitment of clathrin from
the permeabilised cell membranes. This idea is supported
by the requirement for clathrin for efficient sequestration
of ligand in permeabilised cells that have been subjected
to a more stringent washing procedure. We cannot rule out
the possibility, however, that residual cytosolic clathrin
that has not been removed from the cells during the per-
meabilisation procedure is sufficient to support the forma-
tion of new coated pits in this system.
Depletion of ATP prevents de novo coated pit assembly.
This result extends previous studies showing that new
coated pit formation is dependent on the presence of both
cytosol and ATP [10]. Similarly, in permeabilised NRK
cells, the recruitment of exogenously added adaptors to
the plasma membrane has been shown to be ATP-depen-
dent [39]. It will be interesting to define the precise role
played by ATP in new pit formation: ATP could be essen-
tial for new pit assembly, or alternatively it could be
required for the release of clathrin from the permeabilised
cell membranes.
Rab5–GDI acts after coat assembly
By a combination of morphological and biochemical
assays, we have established that Rab5–GDI acts after coat
assembly and is essential for the efficient sequestration of
ligand. Figure 7 shows a schematic model of how we
believe Rab5–GDI acts in this system. Coat proteins are
recruited to the membrane in an ATP-dependent manner.
Although lattices are formed under these conditions, these
lattices become capable of ligand sequestration only after
recruitment of Rab5–GDI. Although exogenous Rab5
does not support sequestration or internalisation in the
absence of adaptors, removal of Rab5 inhibits these
processes. Our conclusion on the basis of these data is that
Rab5 is incorporated early in clathrin-coated pit assembly
and hence is required for the sequestration of ligand into
newly formed coated pits (measured by the adaptor-
dependent signal). The pre-existing pits that sequester or
internalise ligand have therefore already recruited Rab5,
so exogenously added Rab5 has no effect. As expected,
immunodepletion of Rab5 from cytosol has no effect on
the ability of the cytosol to support sequestration or inter-
nalisation through pre-existing pits in the avidin and
MesNa assays (data not shown). 
Our data support the hypothesis that the processes of coat
assembly and invagination are separately regulated, con-
sistent with observations made in this and other systems.
It has been previously shown that A431 cell membranes
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could be ‘primed’ by pre-incubation with adaptors. The
unbound adaptors could then be removed and sequestra-
tion could still occur, provided that cytosol and ATP were
added in the subsequent reaction [12]. Purified
Rab5–GDI is also able to support sequestration by
adaptor-primed membranes (H.M. and E.S., unpublished
observations). Other studies show that high levels of trans-
ferrin receptor expression can promote the formation of
clathrin lattices with up to 30% of the cell surface being
covered. There is no increase in the number of invagi-
nated coated pits, however [40]. These lattices appear to
be relatively long-lived, suggesting that components
required for invagination are limiting in this system. 
Implications for vesicular membrane traffic
The requirement for Rab5–GDI for sequestration indi-
cates that the recruitment of essential components of the
targeting and fusion machinery necessary for later trans-
port steps is closely coupled to the formation of functional
clathrin-coated vesicles. Although this is the first demon-
stration of a direct role for a Rab protein in clathrin-coated
pit formation, other studies have implicated a role for
functional Rab1 in the budding of COP I-coated vesicles
from the ER [41–43]. Rab1 is also required at later stages
of docking and fusion [44]. Yeast transport vesicles can
recruit ypt1, the yeast homologue of Rab1, after budding
has occurred [45,46]. Similarly, clathrin-coated vesicles
from mammalian cells can recruit Rab5 [38], although it
has also been reported that during the purification of
coated vesicles the associated Rab5 is lost [23], and this
Rab5 might then be able to rebind the vesicles. Our
demonstration of a direct role for Rab5–GDI in clathrin-
coated pit formation suggests that there are strong mecha-
nistic similarities in the way that different transport
vesicles are formed.
We have shown that Rab5–GDI is required for clathrin-
coated pit invagination and it is intriguing to speculate
about the mechanism of action of the complex in this
process. One possibility is that Rab5–GDI has a direct role
in promoting sequestration, either by driving invagination
or by receptor recruitment. A second possibility is that
there is a molecular ‘sensor’ that ensures that Rab5 is
recruited to the growing pit for its subsequent role in tar-
geting and fusion reactions, in other words, there is a
quality-control mechanism which ensures that functional
transport vesicles only form if they contain all of the com-
ponents needed for the next stage in transport. A third
possibility is that the role of Rab5 in targeting and fusion
of endocytic vesicles is mediated by events that occur
early in coated pit formation. In this context, it is interest-
ing to note that recent studies from other systems have
implicated NSF (N-ethylmaleimide-sensitive fusion
protein) and SNAPs (soluble NSF attachment proteins),
components known to be involved in vesicle docking and
fusion, in pre-docking or vesicle budding events [19,47].
Given that these components are known to interact with
SNAREs, a number of hypotheses have been proposed to
account for the action of these components, including
reactivation of SNAREs following a fusion event, and reg-
ulation of the interaction of SNAREs with fusion partners
or with other essential components of the transport
machinery [19]. The Rab/ypt1 family has been proposed
to have related roles in the regulation of SNAREs, so it
may well be that Rab proteins also perform part or all of
their function at a very early stage of vesicle budding.
In conclusion, we provide a model whereby the invagina-
tion of a coated pit and its ability to sequester ligand is
dependent on the recruitment of Rab5 from the cytosol,
where it exists as a complex with GDI. An investigation of
the events upstream and downstream of the recruitment
of Rab5–GDI should further elucidate the mechanism of
coated pit assembly and function.
Materials and methods
Preparation of Rab5–GDI
Cytosol was prepared from bovine brains (PelFreez) stored at –80°C.
Thawed brains were homogenised in an equal volume of KSHM buffer
(100 mM potassium acetate, 85 mM sucrose, 1 mM MgCl2, 20 mM
HEPES pH 7.4). After centrifugation at 10,000 rpm for 30 min in a
Beckman JA10 rotor, the supernatant was further centrifuged at
25,000 rpm in a Beckman Ti45 rotor. The supernatant was applied to a
300 ml reactive red dye matrix (Sigma) equilibrated in KSHM buffer.
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Figure 7
Proposed role of Rab5–GDI in clathrin-coated pit formation. This figure
summarises the proposed role of Rab5–GDI in clathrin-coated pit
formation, on the basis of our studies. Coat proteins are recruited to
the membrane of permeabilised cells in an ATP-dependent fashion.
GDI delivers Rab5 to the membrane to promote efficient sequestration
of ligand. Nucleotide exchange occurs and GDI dissociates. Rab5 is
needed for all steps on the pathway to coated vesicle formation.
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After washing, Rab5–GDI was eluted from the column with 7.5 mM
pyruvic acid in KSHM and concentrated by 60% ammonium sulphate
precipitation. The protein precipitates were resuspended in KSHM. Fol-
lowing dialysis, the protein was loaded onto a MonoQ ion-exchange
column (Pharmacia) equilibrated in KSHM. After washing, Rab5–GDI
was eluted using a linear gradient between 0.1 and 0.28 M KCl in
KSHM. Fractions containing Rab5–GDI were pooled and dialysed
overnight against 0.02 M sodium acetate pH 5.2, containing 0.5 M
sucrose. This sample was then applied to a 1 ml phosphocellulose
column, prepared according to manufacturers’ instructions and equili-
brated in start buffer (0.02 M sodium acetate pH 5.2, 0.5 M sucrose).
Rab5–GDI flowed through the column, whereas almost all of the
remaining contaminating proteins in the preparation bound to the phos-
phocellulose. The flow-through was concentrated (0.1–0.2 mg/ml). Gel
filtration of this fraction was carried out on a Pharmacia SMART system
using a Superdex 200 column equilibrated in KSHM containing
100 µM GDP. The final purified fraction consisted of two major bands
of 58 kDa and 27 kDa. In some preparations, there was also a minor
contaminant of 23 kDa (also present in some inactive fractions).
Sequence analysis of this band has shown it to be thiol-specific antioxi-
dant protein (data not shown). Purified fractions were stored at –80°C.
Antibodies
Antiserum against GDI was raised in sheep by the Scottish Antibody
Production Unit. Peptides corresponding to the following sequences:
(1) KRKQNDVFGEADQ, and (2) GESSSITPLEELYK (in single-letter
amino-acid code), were coupled to BSA and keyhole limpet haemo-
cyanin using glutaraldehyde.
Assay for adaptor-dependent stimulation of sequestration
The assays for avidin inaccessibility, MesNa resistance and adaptor-
dependent stimulation of transferrin sequestration were carried out as
previously described [48,49].
Other methods
All other methods were carried out according to published procedures.
Further details are available as supplementary material.
Supplementary material
Additional methodological detail and two figures showing Superdex
200 fraction profiles, and electron micrographs used to perform the
quantitation shown in Table 2, are available with the internet version of
this paper.
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